Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$2.9M in Q3 2026 · $39.4M over twelve months
Operating cash flow$14.3M
Capital spending−$11.4M
Free cash flow+$2.9M
Cash / net income0.5×
Analysis
In Q3 2026, Quaker Chemical generated $14.3M of operating cash flow and spent $11.4M on capital projects, leaving free cash flow of $2.9M. That is $35.2M less than in Q3 2025 ($38.0M).
Over the twelve months to Sep 30, 2026, operating cash flow was $94.1M; the largest uses were net borrowing (+) / repaid (−) ($777M), capital spending ($54.7M), dividends ($35.2M); besides operations, cash came from other financing ($799M), other investing ($4.5M); the cash balance fell by $5.0M.
Operating cash flow was $14.3M against net income of $30.0M — 0.5× profit, less cash than reported earnings, worth checking against working capital. The largest differences: receivables −$25.3M, depreciation & amortization +$17.5M, inventory −$16.5M.
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $14.3M, Capital spending $11.4M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $711M; the largest uses were acquisitions ($259M) and net borrowing ($242M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$167M
Debt$890M
Net debt$723M
Due within a year$35.2M
Quaker Chemical funds itself: free cash flow was $39.4M over the last twelve months, and $167M of cash and investments stands against $890M of debt ($35.2M due within a year, 4.7× covered by cash).
Principal due in each year as disclosed in the annual report, against $167M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Buybacks
Dividends
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$14.3M
−$11.4M
—
−$3.3M
−$8.7M
$20.0M
−$269K
−$11.9M
$2.9M
Q2 2026
$29.5M
−$10.4M
—
—
−$8.8M
−$796M
−$6K
$14.6M
$19.1M
Q1 2026
$3.8M
−$10.7M
—
—
−$8.8M
$7.1M
−$1.7M
$10.1M
−$6.9M
Q4 2025
$46.5M
−$22.2M
—
−$5.0M
−$8.8M
−$8.6M
−$288K
−$7.8M
$24.3M
Q3 2025
$51.4M
−$13.3M
−$131K
−$3.8M
−$8.4M
−$56.2M
$202K
$29.9M
$38.0M
Q2 2025
$41.6M
−$8.0M
−$160M
—
−$8.6M
−$8.0M
−$125K
−$15.7M
$33.6M
Q1 2025
−$3.0M
−$12.3M
−$4.0M
—
−$8.6M
−$9.3M
−$1.2M
$2.7M
−$15.4M
Q4 2024
$63.1M
−$22.5M
—
−$26.3M
−$8.6M
−$6.3M
−$1.8M
$23.2M
$40.6M
Quaker Chemical: income statement and cash flow
Quaker Chemical, Q3 2026: revenue $545M (+10% year over year), operating margin 9.0%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.